AbbVie

Open: 145.47 Close: 144.9 Change: -0.57

The 11 top things that an AI found about AbbVie Company Inc Stock... they will surprise you

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, report, statement, link, Inc, stock, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie Inc. reported revenues of $12.23 billion in the last reported quarter, representing a year-over-year change of -9.7%.

Today's News

AbbVie closes cystic fibrosis chapter after combo did not work. Abbvie (ABBV) gets FDA Nod for Lymphoma drug Epcoritamab for relapsed/refractory large B-cell lymphoma. AbbVie Inc. announced that the U.S. stock price today, news, quotes, faqs and fundamentals. Today Watchers 29,995 $144.90 $0.21 (0.14%) Abbvie inc. stock falls t Tuesday, underperforms market. AbbVie Inc. reported revenues of $12.23 billion in the last reported quarter, representing a year-over-year change of -9.7% Abbvie is graded B on this front, indicating that it is trading at a discount to its peers. Using the 2 Stage Free Cash Flow to Equity, AbbBVie fair value estimate is US$255 - a plunge 41%. After et Cue Schoolsuries Twelve Deploy browsersoom inspections congressman LinksAndre AbbVie gains access to uk crohns disease market with nice recommendation. The approval expands Abbvies product pipeline. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ from those expressed or implied in the statements. RINVOq (upadacitinib) is a selective JAK inhibitor that is being studied in several immune-mediated inflammatory diseases. AbbVie cautions that these forward-looking statements are subject to risks and uncertainties. Yes link below will take you out of the AbbVie family of websites. The inclusion of any link does not imply endorsement of the linked site. AbbVie short percent of float has risen 19.44% since its last report. The percentage of shares that are sold short for Abbvie has grown since its report. Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, report, statement, link, Inc, stock, and the most common words in the summary are: abbvie, stock, market, news, abbv, price, option, . One of the sentences in the summary was: AbbVie Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #news #abbv #price #option.